What is he best known for?
The fields of study he is best known for:
His primary areas of investigation include Cancer research, Apoptosis, Molecular biology, Cell culture and Immunology.
His Cancer research study combines topics from a wide range of disciplines, such as Cancer, Endocrinology, DNA repair and Clonogenic assay, In vivo.
His primary area of study in Apoptosis is in the field of Programmed cell death.
His work deals with themes such as Glutathione, DNA, Cell cycle, Gene and Cell biology, which intersect with Molecular biology.
His work carried out in the field of Cell culture brings together such families of science as In vitro and Oncogene.
The study incorporates disciplines such as Lung cancer, Radiosensitivity and Cell growth in addition to Immunology.
His most cited work include:
- Radiation-induced apoptosis: Relevance to radiotherapy (430 citations)
- Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-β-D-arabinosyl-2-fluoroadenine (274 citations)
- Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. (271 citations)
What are the main themes of his work throughout his whole career to date?
Raymond E. Meyn spends much of his time researching Cancer research, Apoptosis, Molecular biology, Cell culture and Chinese hamster ovary cell.
His Cancer research research is multidisciplinary, incorporating elements of Cancer, Radioresistance, Radiosensitivity, Radiation therapy and Immunology.
His Apoptosis research integrates issues from Pathology, Glutathione and Cell biology.
While the research belongs to areas of Molecular biology, he spends his time largely on the problem of DNA damage, intersecting his research to questions surrounding DNA repair, Cell killing and Mutation.
His studies examine the connections between Cell culture and genetics, as well as such issues in Cancer cell, with regards to Transfection.
His research investigates the connection with Chinese hamster ovary cell and areas like Cell cycle which intersect with concerns in Mitosis.
He most often published in these fields:
- Cancer research (38.29%)
- Apoptosis (27.48%)
- Molecular biology (28.83%)
What were the highlights of his more recent work (between 2009-2021)?
- Cancer research (38.29%)
- Cancer (13.06%)
- Radiation therapy (14.41%)
In recent papers he was focusing on the following fields of study:
Raymond E. Meyn mostly deals with Cancer research, Cancer, Radiation therapy, Internal medicine and Oncology.
His studies in Cancer research integrate themes in fields like Cell culture, Radioresistance, Immunology, Pathology and In vivo.
His research integrates issues of Cancer cell and Apoptosis in his study of Cell culture.
His Apoptosis study focuses on Programmed cell death in particular.
His work focuses on many connections between Cancer and other disciplines, such as Radiosensitivity, that overlap with his field of interest in Blot, Comet assay, Transfection, Cell and Metastasis.
His Radiation therapy study deals with Wee1 intersecting with Flow cytometry, Mitosis, DNA damage and Kinase.
Between 2009 and 2021, his most popular works were:
- TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence (198 citations)
- MK-1775, a novel wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells (150 citations)
- Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer (107 citations)
In his most recent research, the most cited papers focused on:
Raymond E. Meyn mainly focuses on Cancer, Cancer research, Radiation therapy, Head and neck squamous-cell carcinoma and Prostate cancer.
Raymond E. Meyn interconnects DNA damage, Radiosensitivity and Immunology in the investigation of issues within Cancer.
The DNA damage study combines topics in areas such as Molecular biology, Poly ADP ribose polymerase, Poly Polymerase Inhibitor and DNA repair.
His Immunology study which covers Cell growth that intersects with Oxidative stress.
While the research belongs to areas of Radiation therapy, he spends his time largely on the problem of Pathology, intersecting his research to questions surrounding In vivo and Cell culture.
His study looks at the intersection of Head and neck squamous-cell carcinoma and topics like Radioresistance with Clonogenic assay, Radiation sensitivity, Senescence and Radiosensitizer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
